AdvisorShares Psychedelics ETF(PSIL · ETF)

ETF quote, holdings, sector allocation, technicals, and options analytics.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Snapshot
$20.11
52-Week Range
$13.40 – $22.49
YTD
+16.92%
IV Rank (30D)
35.09
Straddle Price
$2.35
P/C Vol Ratio
0.59
Info

AdvisorShares Psychedelics ETF (PSIL) ETF

Exchange
ARCX
Inception
2021-09-15
Has Options
Yes
ETF Profile
holdings as of 2026-06-30
Holdings
29
AUM
$18.5M
Provider
Unknown
Inception
2021-09-15
Exchange
ARCX
Data As Of
2026-06-30
Expense Ratio
Dividend Yield
8.51%
Distribution
Quarterly
Recent distributions
Ex-Date Pay Date Amount Type
2025-12-22 2025-12-29 $1.6839 CD
2025-09-22 2025-09-29 $0.0201 CD
2025-06-23 2025-06-27 $0.0119 CD
2025-03-21 2025-03-28 $0.1634 CD
2024-12-23 2024-12-30 $0.0548 CD
2024-09-23 2024-09-30 $0.1087 CD
Asset Allocation
Top Holdings
top 29 of 29 holdings
Symbol Name Weight % Asset Class Country
DREY INST PREF GOV MM-M 17.77% Short-term investment US
VALU Atai Beckley NV 12.14% Equity (common) NL
CMPS Compass Pathways Plc 8.62% Equity (common) GB
RLMD Relmada Therapeutics Inc 8.35% Equity (common) US
SUPN Supernus Pharmaceuticals Inc 7.64% Equity (common) US
DFTX Mind Medicine MindMed Inc 7.45% Equity (common) US
NRXP NRX Therapeutics Inc 4.81% Equity (common) US
VALU Alkermes PLC 4.63% Equity (common) IE
VALU GH Research PLC 4.61% Equity (common) IE
NBIX Neurocrine Biosciences Inc 4.53% Equity (common) US
HELP Cybin Inc 4.34% Equity (common) CA
ANRO Alto Neuroscience Inc 4.25% Equity (common) US
DRUG Bright Minds Biosciences Inc 4.20% Equity (common) US
BLACKROCK TREASURY TRUST 4.09% Short-term investment US
ABBV AbbVie Inc 3.64% Equity (common) US
JNJ Johnson & Johnson 3.42% Equity (common) US
NEUP Neuphoria Therapeutics Inc 2.82% Equity (common) US
KTTA Pasithea Therapeutics Corp 2.13% Equity (common) US
STIM Neuronetics Inc 2.02% Equity (common) US
QNTM Quantum BioPharma Ltd 1.96% Equity (common) CA
Incannex Healthcare Inc 1.29% Equity (common) AU
SILO Silo Pharma Inc 1.10% Equity (common) US
VTGN Vistagen Therapeutics Inc 0.90% Equity (common) US
NUMIF Numinus Wellness Inc 0.79% Equity (common) CA
ENVB Enveric Biosciences Inc 0.33% Equity (common) US
CMND Clearmind Medicine Inc 0.07% Equity (common) CA
VALU QUANTUM BIOPHARMA 0.00% Equity (common) CA
VALU SAGE THERAPEUTICS INC 0.00% Equity (common) US
VALU UNBUZZD WELLNESS INC 0.00% Equity (common) CA
Geographic Breakdown
Fund Holdings
AdvisorShares Psychedelics ETF · NPORT-P period 2026-06-30 (filed 2026-02-23)
Net assets: $18M · 29 total positions · equity 96.04% · non-equity 21.86%
# Symbol Issuer Weight Value
1 Atai Beckley NV Atai Beckley NV 12.14% $2.2M
2 Compass Pathways Plc Compass Pathways Plc 8.62% $1.6M
3 Relmada Therapeutics Inc Relmada Therapeutics Inc 8.35% $1.5M
4 Supernus Pharmaceuticals Inc Supernus Pharmaceuticals Inc 7.64% $1.4M
5 Mind Medicine MindMed Inc Mind Medicine MindMed Inc 7.45% $1.4M
6 NRX Therapeutics Inc NRX Therapeutics Inc 4.81% $888891
7 Alkermes PLC Alkermes PLC 4.63% $855628
8 GH Research PLC GH Research PLC 4.61% $852322
9 Neurocrine Biosciences Inc Neurocrine Biosciences Inc 4.53% $836939
10 Cybin Inc Cybin Inc 4.34% $802114
11 Alto Neuroscience Inc Alto Neuroscience Inc 4.25% $784571
12 Bright Minds Biosciences Inc Bright Minds Biosciences Inc 4.20% $776030
13 AbbVie Inc AbbVie Inc 3.64% $672446
14 Johnson & Johnson Johnson & Johnson 3.42% $632439
15 Neuphoria Therapeutics Inc Neuphoria Therapeutics Inc 2.82% $520673
16 Pasithea Therapeutics Corp Pasithea Therapeutics Corp 2.13% $393090
17 Neuronetics Inc Neuronetics Inc 2.02% $373864
18 Quantum BioPharma Ltd Quantum BioPharma Ltd 1.96% $362321
19 Incannex Healthcare Inc Incannex Healthcare Inc 1.29% $237614
20 Silo Pharma Inc Silo Pharma Inc 1.10% $203832
21 Vistagen Therapeutics Inc Vistagen Therapeutics Inc 0.90% $165599
22 Numinus Wellness Inc Numinus Wellness Inc 0.79% $145173
23 Enveric Biosciences Inc Enveric Biosciences Inc 0.33% $61616
24 Clearmind Medicine Inc Clearmind Medicine Inc 0.06% $12004
25 QUANTUM BIOPHARMA QUANTUM BIOPHARMA 0.00%
Showing top 25 of 27 equity holdings.
Non-equity holdings — 2 positions, 21.86% of NAV
Category Weight Value Positions
Short-term investment 21.86% $4.0M 2
Price History
Seasonality
MonthAvg ReturnYears of Data
Jan +1.08% 5
Feb -2.97% 5
Mar -5.28% 5
Apr -7.35% 5
May -0.81% 5
Jun -5.38% 5
Jul +11.83% 4
Aug +1.92% 4
Sep -10.28% 5
Oct +7.41% 5
Nov -8.52% 5
Dec -11.90% 5
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $20.38
SMA 50: $19.73
SMA 200: $18.39
Current: $20.16
EMA 12: $20.11
EMA 26: $20.12
MACD: -0.0082 | Signal: -0.1971
BULLISH
ADX (14): 24.41
WEAK TREND
+DI: 23.00
−DI: 26.09
Momentum Oscillators
RSI (14): 50.53
NEUTRAL
Stoch %K: 24.97
Stoch %D: 18.60
Williams %R: -61.47
Volume & Volatility
BB Upper: $22.08
BB Lower: $18.68
NEUTRAL
OBV: 443,792
Vol SMA 20: 31,687
Vol ROC: -60.82%
ATR: $0.76
True Range: $0.73
HV 20: 40.5%
HV 30: 35.6%
HV 60: 39.9%

Data Summary
Data Points: 500
Last Updated: 2026-06-12T21:15:24.102000
Date Range: 2024-06-14T00:00:00 – 2026-06-12T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Options Activity
IV Rank (30D)
35.09
IV Rank (7D)
100
Avg IV
68.8%
Straddle (30D)
$2.35
Straddle (7D)
$1.67
P/C Volume
0.59
Spread Scanner GPU

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Volatility Surface

Enter a ticker to render the implied volatility surface.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
1.48
Correlation (SPY)
42.8%
0.18
Ann. Volatility
42.7%
SPY Volatility
12.3%

High volatility - stock moves more than market

Beta & Alpha Over Time
Constituent Performance

Click any bar to view the full quote for that stock.

Constituents
Symbol Price 1 Day 1 Week 1 Month